BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32386813)

  • 1. Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout.
    Carnicelli AP; Clare R; Chiswell K; Lytle B; Bjursell M; Perl S; Andersson K; Hedman K; Pagidipati N; Vemulapalli S; Roe MT; Mentz RJ
    Am J Cardiol; 2020 Jul; 127():64-72. PubMed ID: 32386813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Hyperuricemia in Patients With Acute Heart Failure With Either Reduced or Preserved Ejection Fraction.
    Palazzuoli A; Ruocco G; De Vivo O; Nuti R; McCullough PA
    Am J Cardiol; 2017 Oct; 120(7):1146-1150. PubMed ID: 28807403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M
    J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study).
    Caughey MC; Sueta CA; Stearns SC; Shah AM; Rosamond WD; Chang PP
    Am J Cardiol; 2018 Jul; 122(1):108-114. PubMed ID: 29703442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.
    Wolsk E; Claggett B; Køber L; Pocock S; Yusuf S; Swedberg K; McMurray JJV; Granger CB; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2018 Mar; 20(3):504-510. PubMed ID: 29193462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
    Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
    Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Heart Fail Rev; 2019 Nov; 24(6):847-866. PubMed ID: 31147814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction.
    Shimizu T; Yoshihisa A; Kanno Y; Takiguchi M; Sato A; Miura S; Nakamura Y; Yamauchi H; Owada T; Abe S; Sato T; Suzuki S; Oikawa M; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
    Am J Physiol Heart Circ Physiol; 2015 Oct; 309(7):H1123-9. PubMed ID: 26297226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.
    Tromp J; Shen L; Jhund PS; Anand IS; Carson PE; Desai AS; Granger CB; Komajda M; McKelvie RS; Pfeffer MA; Solomon SD; Køber L; Swedberg K; Zile MR; Pitt B; Lam CSP; McMurray JJV
    J Am Coll Cardiol; 2019 Aug; 74(5):601-612. PubMed ID: 31370950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke and Systemic Embolism and Other Adverse Outcomes of Heart Failure With Preserved and Reduced Ejection Fraction in Patients With Atrial Fibrillation (from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation [CODE-AF]).
    Chung S; Kim TH; Uhm JS; Cha MJ; Lee JM; Park J; Park JK; Kang KW; Kim J; Park HW; Choi EK; Kim JB; Kim CS; Lee YS; Shim J; Joung B
    Am J Cardiol; 2020 Jan; 125(1):68-75. PubMed ID: 31699363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance).
    Caughey MC; Avery CL; Ni H; Solomon SD; Matsushita K; Wruck LM; Rosamond WD; Loehr LR
    Am J Cardiol; 2014 Dec; 114(12):1850-4. PubMed ID: 25438912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Risk of Re-hospitalization, All-Cause Mortality, and Medical Care Resource Utilization in Patients With Heart Failure and Preserved Versus Reduced Ejection Fraction.
    Nichols GA; Reynolds K; Kimes TM; Rosales AG; Chan WW
    Am J Cardiol; 2015 Oct; 116(7):1088-92. PubMed ID: 26235928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The associations among co-morbidity, cardiac geometries and mechanics in hospitalized heart failure with or without preserved ejection fraction.
    Lo CI; Lai YH; Chang SN; Kuo JY; Hsieh YC; Bulwer BE; Hung CL; Yeh HI
    Clin Exp Hypertens; 2017; 39(5):473-480. PubMed ID: 28569600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: outcomes following an acute heart failure hospitalization.
    Buggey J; Alenezi F; Yoon HJ; Phelan M; DeVore AD; Khouri MG; Schulte PJ; Velazquez EJ
    ESC Heart Fail; 2017 Nov; 4(4):432-439. PubMed ID: 29154416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex Differences in Heart Failure With Preserved Ejection Fraction.
    Sotomi Y; Hikoso S; Nakatani D; Mizuno H; Okada K; Dohi T; Kitamura T; Sunaga A; Kida H; Oeun B; Sato T; Komukai S; Tamaki S; Yano M; Hayashi T; Nakagawa A; Nakagawa Y; Yasumura Y; Yamada T; Sakata Y;
    J Am Heart Assoc; 2021 Feb; 10(5):e018574. PubMed ID: 33619973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.
    Agra Bermejo R; Gonzalez Babarro E; López Canoa JN; Varela Román A; Gómez Otero I; Oro Ayude M; Parada Vazquez P; Gómez Rodríguez I; Díaz Castro O; González Juanatey JR
    Cardiol J; 2018; 25(3):353-362. PubMed ID: 28980289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.